KPTI
Karyopharm Therapeutics Inc
0.8022$
-7.5%
vs. previous close
Closing price · As of: Oct 2, 2026
Statements
Balance Sheet
All figures as a percentage of total assets in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 97.5% | 97.3% | 97.0% | 97.5% | 97.5% | 95.2% | 94.1% | 93.3% | 93.3% | 95.1% | 96.1% | 95.6% | |
| 16.2% | 21.7% | 15.0% | 39.6% | 38.4% | 38.0% | 30.4% | 36.9% | 39.1% | 55.8% | 69.1% | 49.4% | |
| 77.2% | 79.6% | 72.7% | 71.1% | 70.5% | 66.1% | 54.8% | 49.3% | 47.7% | 58.8% | 69.1% | 58.5% | |
| 14.0% | 11.2% | 15.2% | 17.8% | 16.8% | 18.7% | 27.6% | 31.4% | 33.1% | 24.1% | 17.8% | 26.8% | |
| 1.2% | 1.3% | 1.4% | 1.6% | 2.5% | 2.9% | 3.7% | 4.8% | 4.1% | 3.7% | 2.7% | 3.6% | |
| 137.2% | 156.6% | 182.6% | 161.8% | 184.3% | 213.1% | 261.2% | 327.8% | 379.8% | 370.2% | 302.1% | 396.6% | |
| 23.0% | 28.9% | 32.0% | 26.9% | 32.5% | 56.1% | 70.8% | 94.6% | 90.6% | 84.9% | 89.3% | 120.6% | |
| 1.2% | 1.4% | 1.7% | 1.7% | 1.9% | 15.1% | 19.9% | 30.6% | 14.2% | 20.3% | 25.3% | 1.0% | |
| 0.3% | 1.3% | 2.5% | 1.3% | 3.1% | 3.1% | 4.6% | 2.5% | 5.6% | 3.7% | 3.3% | 6.9% | |
| 63.2% | 71.1% | 83.7% | 89.3% | 100.6% | 99.1% | 121.2% | 145.2% | 183.7% | 189.9% | 146.2% | 188.3% | |
| -37.2% | -56.6% | -82.6% | -61.8% | -84.3% | -113.1% | -161.2% | -227.8% | -279.8% | -270.2% | -202.1% | -296.6% | |
| -535.3% | -618.5% | -745.6% | -701.3% | -808.9% | -950.9% | -1,242.6% | -1,548.6% | -1,722.2% | -1,622.9% | -1,355.9% | -1,660.9% | |
| 2.8% | 3.2% | 3.8% | 4.8% | 4.4% | 5.1% | 6.6% | 8.2% | 9.0% | 16.8% | 18.8% | 26.0% |
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.